Literature DB >> 16840580

Attenuated gastric distress but no benefit to performance with adaptation to octanoate-rich esterified oils in well-trained male cyclists.

Megan S Thorburn1, Bodil Vistisen, Rhys M Thorp, Mike J Rockell, Asker E Jeukendrup, Xuebing Xu, David S Rowlands.   

Abstract

We investigated the effects of modifying a normal dietary fatty acid composition and ingestion of high-fat exercise supplements on gastrointestinal distress, substrate oxidation, and endurance cycling performance. Nine well-trained male cyclists completed a randomized triple-crossover comprising a 2-wk diet high in octanoate-rich esterified oil (MCFA) or twice long-chain fatty acids (LCFA). Following the diets, participants performed 3-h of cycling at 50% of peak power followed by 10 maximal sprints while ingesting either 1) a carbohydrate (CHO)+MCFA-rich oil emulsion after the 2-wk MCFA-rich dietary condition (MC-MC, Intervention) and 2) after one of the LCFA-rich dietary conditions (LC-MC, Placebo) or 3) CHO only following a LCFA-rich diet (LC-CHO, Control). During the 3-h ride MCFA-adaptation decreased octanoic-acid oxidation by 24% (90% confidence interval: 14-34%). The CHO+MCFA-rich oil emulsion reduced endogenous fat oxidation by 61% (33-89%) and 110% (89-131%) in the MC-MC and LC-MC conditions, respectively, and MCFA-adaptation reduced endogenous-carbohydrate oxidation by 10% (-3-23%). MCFA-adaptation attenuated gastrointestinal distress and nausea during the sprints, but the effect of the oil emulsion was to lower sprint power by 10.9% (7.7-14.1%) in the LC-MC condition and by 7.1% (5.7-8.5%) in the MC-MC condition, relative to the LC-CHO control; every one unit increase in nausea decreased mean power by 6.0 W (3.2-8.8 W). We conclude that despite some attenuation of endogenous-carbohydrate oxidation and gastric distress following adaptation to a MCFA-rich diet, repeat sprint performance was substantially impaired in response to the ingestion of a CHO+MCFA-rich oil emulsion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840580     DOI: 10.1152/japplphysiol.00393.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

Review 1.  ISSN exercise & sports nutrition review update: research & recommendations.

Authors:  Chad M Kerksick; Colin D Wilborn; Michael D Roberts; Abbie Smith-Ryan; Susan M Kleiner; Ralf Jäger; Rick Collins; Mathew Cooke; Jaci N Davis; Elfego Galvan; Mike Greenwood; Lonnie M Lowery; Robert Wildman; Jose Antonio; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2018-08-01       Impact factor: 5.150

Review 2.  Fructose-Glucose Composite Carbohydrates and Endurance Performance: Critical Review and Future Perspectives.

Authors:  David S Rowlands; S Houltham; K Musa-Veloso; F Brown; L Paulionis; D Bailey
Journal:  Sports Med       Date:  2015-11       Impact factor: 11.136

3.  L-Arginine but not L-glutamine likely increases exogenous carbohydrate oxidation during endurance exercise.

Authors:  David S Rowlands; Jim Clarke; Jackson G Green; Xiaocai Shi
Journal:  Eur J Appl Physiol       Date:  2011-11-03       Impact factor: 3.078

4.  Carbohydrate hydrogel beverage provides no additional cycling performance benefit versus carbohydrate alone.

Authors:  Daniel A Baur; Harrison R Toney; Michael J Saunders; Katherine G Baur; Nicholas D Luden; Christopher J Womack
Journal:  Eur J Appl Physiol       Date:  2019-10-09       Impact factor: 3.078

5.  Increased exogenous but unaltered endogenous carbohydrate oxidation with combined fructose-maltodextrin ingested at 120 g h-1 versus 90 g h-1 at different ratios.

Authors:  Tim Podlogar; Špela Bokal; Simon Cirnski; Gareth A Wallis
Journal:  Eur J Appl Physiol       Date:  2022-08-11       Impact factor: 3.346

Review 6.  Carbohydrate supplementation: a critical review of recent innovations.

Authors:  Daniel A Baur; Michael J Saunders
Journal:  Eur J Appl Physiol       Date:  2020-10-27       Impact factor: 3.078

Review 7.  Exogenous Ketones and Lactate as a Potential Therapeutic Intervention for Brain Injury and Neurodegenerative Conditions.

Authors:  Naomi Elyse Omori; Geoffrey Hubert Woo; Latt Shahril Mansor
Journal:  Front Hum Neurosci       Date:  2022-04-28       Impact factor: 3.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.